Lifecore Biomedical
LFCR
LFCR
78 hedge funds and large institutions have $114M invested in Lifecore Biomedical in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% less ownership
Funds ownership: 72.57% → 70.57% (-2%)
16% less capital invested
Capital invested by funds: $136M → $114M (-$21.8M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
78
Holding in Top 10
4
Calls
$778K
Puts
$492K
Top Buyers
| 1 | +$1.98M | |
| 2 | +$846K | |
| 3 | +$772K | |
| 4 |
3C
325 Capital
New York
|
+$710K |
| 5 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$503K |
Top Sellers
| 1 | -$4.17M | |
| 2 | -$1.18M | |
| 3 | -$880K | |
| 4 |
BlackRock
New York
|
-$640K |
| 5 |
DC
Defender Capital
Charlotte,
North Carolina
|
-$535K |